Table 4 Causes of failure of the test at 36 weeks PMA
Adverse event | Baseline (N 0) | Challenge (N 4) | Post-test (N 2) |
|---|---|---|---|
Apnea | 0 | 0 | 0 |
Bradycardia | 0 | 0 | 0 |
SpO2 80–90% with TcPO2 < 50 mmHg for > 5’ | 0 | 2 | 1 |
SpO2 < 80% for 1′ | 0 | 2 | 1 |
Adverse event | Baseline (N 0) | Challenge (N 4) | Post-test (N 2) |
|---|---|---|---|
Apnea | 0 | 0 | 0 |
Bradycardia | 0 | 0 | 0 |
SpO2 80–90% with TcPO2 < 50 mmHg for > 5’ | 0 | 2 | 1 |
SpO2 < 80% for 1′ | 0 | 2 | 1 |